01 1Novartis Pharmaceuticals Canada Inc.
02 10Novo Nordisk Canada Inc.
03 7Blank
01 71306212
02 112258097
01 3INSULIN ASPART
02 8Insulin Aspart
03 7Blank
01 8Liquid
02 3SOLUTION
03 7Blank
01 72009-08-11
02 112017-06-19
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : FIASP
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 units pr. mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 30
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 50
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 50
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 70
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 70
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVORAPID
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U/ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVORAPID
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U/ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : NOVOMIX 30
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 U / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
Brand Name : FIASP
Patent Number : 2258097
Filing Date : 1997-06-19
Strength per Unit : 100 units pr. mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2017-06-19
Date Granted : 2011-02-08
LOOKING FOR A SUPPLIER?
